Business Manager Life Science - Belgium, Switzerland
Want to know company name or location? Company managed [?]
- In order to support its development in Belgium, Tour company is looking for a talented Business Manager.
- This entrepreneurial position combines specific sales & business development capabilities together with biopharma and medical devices industry knowledge.
- As a Business Manager, you will be responsible for:
- Identifying new clients & business opportunities within the Belgian Life Science industry for technical and management consulting projects.
- Manage client relationships, answer client’s request for information/proposals,
- Build proposals with our senior consultants to answer client’s requests for time & material projects.
- Liaise with the International Business Development Director, Head of Operations & Head of Apollo to identify and plan the appropriate resources to support the client’s requests.
- Build-up your own business unit within The company
- Adapt services and solutions based on specific market demand,
- Recruit and manage a team of consultants (civil and bio-engineers, industrial pharmacists, scientists...),
- Ensure that both project planning and deliverables meet company client’s highest expectations;
- Manage full P&L and ensure reporting to company’s Board.
- Ability to establish trustful relationships with key players in the Belgian market,
- Leadership skills, business drive and acumen, while humble and dynamic.
- A structured/logical/straight forward approach with all business stakeholders,
- Flexibility, adaptation, anticipation and capacity to push for change.
- Language skills: French and English (Dutch is a plus).
- A Master's degree,
- A strong interest or knowledge of the Life sciences industry
- People management abilities,
- Passion for business growth and people development
- Our company advises Biotechnology, Pharmaceuticals and MedTech european clients in their Quality Assurance strategy and daily organisation.
- Our company's founders have been involved over the last ten years in the Life Science industry, at various responsibilities in Quality Assurance, Regulatory Compliance, Engineering and Business excellence. They witnessed the paradigm shift, which is heavily impacting the industry since early 2000.
- Drop on drug prices, ever increasing pressure of regulatory bodies combined with the boom of generic products, have signed the end of the so-called « blockbuster » model.
- New models are emerging which have to rapidly mix new drug discovery – biotechnology being the engine for innovation – with the flexibility to reduce cost and shortening time-to-market.
- To face such a demanding challenge, Life science organizations, driven by both Management and Quality systems, are forced to adapt accordingly.